These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 16367948)

  • 1. Human cytomegalovirus pp65 lower matrix protein: a humoral immunogen for systemic lupus erythematosus patients and autoantibody accelerator for NZB/W F1 mice.
    Chang M; Pan MR; Chen DY; Lan JL
    Clin Exp Immunol; 2006 Jan; 143(1):167-79. PubMed ID: 16367948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cell epitope of human cytomegalovirus phosphoprotein 65 (HCMV pp65) induced anti-dsDNA antibody in BALB/c mice.
    HoHsieh A; Wang CM; Wu YJ; Chen A; Chang MI; Chen JY
    Arthritis Res Ther; 2017 Mar; 19(1):65. PubMed ID: 28320458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Construction and transfection of eucaryotic expression recombinant vector containing truncated region of UL83 gene of human cytomegalovirus and it's sheltered effect as DNA vaccine].
    Gao RB; Li YQ; Wang ML
    Wei Sheng Wu Xue Bao; 2006 Jun; 46(3):451-5. PubMed ID: 16933619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early diagnosis and monitoring of active HCMV infection in children with systemic lupus erythematosus.
    Zhang C; Shen K; Jiang Z; He X
    Chin Med J (Engl); 2001 Dec; 114(12):1309-12. PubMed ID: 11793860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragment of tegument protein pp65 of human cytomegalovirus induces autoantibodies in BALB/c mice.
    Hsieh AH; Jhou YJ; Liang CT; Chang M; Wang SL
    Arthritis Res Ther; 2011; 13(5):R162. PubMed ID: 21989080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunization.
    Endresz V; Kari L; Berencsi K; Kari C; Gyulai Z; Jeney C; Pincus S; Rodeck U; Méric C; Plotkin SA; Gönczöl E
    Vaccine; 1999 Jan; 17(1):50-8. PubMed ID: 10078607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [VP22 enhances the immunological activity of human cytomegalovirus pp65 DNA vaccine: experimental study with mice].
    Ma DX; Yu XP; Zhang XM; Zhou YB; Li Y; Jia JH; Zhao WM
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(15):1049-52. PubMed ID: 16029549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and humoral immune responses to alphavirus replicon vaccines expressing cytomegalovirus pp65, IE1, and gB proteins.
    Reap EA; Dryga SA; Morris J; Rivers B; Norberg PK; Olmsted RA; Chulay JD
    Clin Vaccine Immunol; 2007 Jun; 14(6):748-55. PubMed ID: 17442845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
    Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
    Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytomegalovirus pp65 peptide-induced autoantibodies cross-reacts with TAF9 protein and induces lupus-like autoimmunity in BALB/c mice.
    Hsieh AH; Kuo CF; Chou IJ; Tseng WY; Chen YF; Yu KH; Luo SF
    Sci Rep; 2020 Jun; 10(1):9662. PubMed ID: 32541894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB.
    Lilja AE; Mason PW
    Vaccine; 2012 Nov; 30(49):6980-90. PubMed ID: 23041121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct DNA immunization of mice with plasmid DNA encoding the tegument protein pp65 (ppUL83) of human cytomegalovirus induces high levels of circulating antibody to the encoded protein.
    Pande H; Campo K; Tanamachi B; Forman SJ; Zaia JA
    Scand J Infect Dis Suppl; 1995; 99():117-20. PubMed ID: 8668934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of autoantibody-secreting cells and long-lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice.
    Starke C; Frey S; Wellmann U; Urbonaviciute V; Herrmann M; Amann K; Schett G; Winkler T; Voll RE
    Eur J Immunol; 2011 Jul; 41(7):2107-12. PubMed ID: 21484784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural characterization of an (NZB x NZW)F1 mouse-derived IgM monoclonal antibody that binds through V region-dependent interactions to murine IgG anti-DNA antibodies.
    Margaritte C; Gilbert D; Brard F; Tron F
    J Autoimmun; 1994 Dec; 7(6):711-25. PubMed ID: 7888030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble human CD83 ameliorates lupus in NZB/W F1 mice.
    Starke C; Steinkasserer A; Voll RE; Zinser E
    Immunobiology; 2013 Nov; 218(11):1411-5. PubMed ID: 23886695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector.
    Schleiss MR; Berka U; Watson E; Aistleithner M; Kiefmann B; Mangeat B; Swanson EC; Gillis PA; Hernandez-Alvarado N; Fernández-Alarcón C; Zabeli JC; Pinschewer DD; Lilja AE; Schwendinger M; Guirakhoo F; Monath TP; Orlinger KK
    Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27795301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and therapy exploration of active human cytomegalovirus infection in 105 lupus patients.
    Zhang J; Dou Y; Zhong Z; Su J; Xu D; Tang F; Zhang X; Zhao Y; Zeng X; Zhang F; You X
    Lupus; 2014 Aug; 23(9):889-97. PubMed ID: 24836584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65).
    Morello CS; Cranmer LD; Spector DH
    J Virol; 2000 Apr; 74(8):3696-708. PubMed ID: 10729145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs.
    Gyulai Z; Endresz V; Burian K; Pincus S; Toldy J; Cox WI; Meric C; Plotkin S; Gönczöl E; Berencsi K
    J Infect Dis; 2000 May; 181(5):1537-46. PubMed ID: 10823751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of monoclonal antibodies against phosphoprotein 65 from human cytomegalovirus.
    Xu LJ; Yao HP; Fan J; Li D; Wu NP
    Hybridoma (Larchmt); 2007 Jun; 26(3):173-7. PubMed ID: 17600500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.